Comparison Of PRISM III, PIM2 And PELOD Scoring Systems In Predicting Mortality For Patients Undergoing Congenital Cardiac Surgery In Pediatric Intensive Care Unit
Sponsor study identifier
observational
116
1 country
1
Study Start
February 1, 2019
Actual (reported)Primary Completion
May 1, 2019
Actual (reported)Study Completion
May 1, 2019
Actual (reported)PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pediatric ICUs(Intensive Care Units). However, the effectiveness of these scoring sistems in a specific group patients undergoing congenital heart surgery(CHS) is unknown. In this study, the investigators aimed primarily to evaluate the success of these scoring systems in predicting mortality and morbiditiy in this specific group and to compare the scoring systems with eachother, and secondly to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2019
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 1, 2019
Actual (reported)May 1, 2019
Actual (reported)May 1, 2019
Actual (reported)April 9, 2021
Actual (reported)April 19, 2021
Actual (reported)evaluate the success of PRISMIII, PIM2 and PELOD scoring systems in predicting mortality and morbidity
Patients younger than 18 years of age who had undergone congenital heart surgery were evaluated on the first postoperative day in the ICU and parameters were recorded. PRISMIII and PELOD scores were calculated using the most abnormal values in the first 24 hours, and PIM2 score was calculated using the data within the first hour.
3 months
morbidity indicators
Morbidity indicators were determined as the length of ICU stay, total hospital stay, re-intubation, surgical revision, complications and re-admission to the ICU.
3 months
clinical outcomes
Clinical outcomes were determined as 7-day mortality and 30-day mortality.
3 months
to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category
3 months
Patients younger than 18 years of age who had undergone congenital heart surgery
siyami ersek TRH
Istanbul, Turkey (Türkiye)
116 participants (actual enrollment reported by the registry).
First Submitted
April 9, 2021
First Posted
April 19, 2021
Study Start
February 1, 2019
Actual (reported)The Effects of Telerehabilitation and Exercise Training in Pediatric Arrhythmia Patients With Pacemakers
Contact the study team to confirm eligibility.
Primary Completion
May 1, 2019
Actual (reported)Study Completion
May 1, 2019
Actual (reported)Last Updated
September 7, 2022
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: